Clinical trial NCT05681559: Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial
Official title: Investigation of Medical Management to Prevent Episodes of Diverticulitis (IMPEDE) Trial
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Diverticulitis
Lead sponsor: University of Washington
Sponsor class: OTHER
Collaborators: name: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted: 2023-01-12
Enrollment: 75
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: This is a randomized trial (n=75) of a Mediterranean style Food Pattern and versus standardized guidance on fiber intake for patients with diverticulitis to evaluate the feasibility of this dietary intervention including willingness to randomize and adherence to a Med-style dietary pattern. The investigators will employ state-of-the-art behavioral interventions in the form of electronic feedback to improve health-related behaviors and support dietary customization based on participants' budget, dietary preferences, and restrictions. The investigators will also examine plasma inflammatory biomarkers (interleukin-6, interleukin-10, and interleukin-1β) and fecal calprotectin at baseline, 6, and 12 months.

Detailed description: This is a feasibility-focused, patient-level randomized trial of an intervention promoting the United States Department of Agriculture (USDA) Healthy Med-Style food pattern versus standardized guidance on fiber intake (standard educational materials related to a high-fiber diet) in patients with a history of diverticulitis. This trial will assess and address barriers to the eventual large-scale trial and lay groundwork for that trial that will focus on the risk of recurrent diverticulitis and other clinical outcomes. The investigators will also compare changes in serum and stool biomarkers of inflammation that are proximal endpoints in the causal path relating a Mediterranean diet pattern's anti-inflammatory properties and recurrence of diverticulitis.

Participants randomized to the USDA Mediterranean-style Food Pattern Arm (called Medi for all) will have access to a "toolbox" that includes education materials (e.g., food pattern tables according to daily caloric intake), recipes, grocery lists, group-based online dietary support, feedback, and reminders to encourage dietary change. Recipes and grocery lists can be individualized to a participant's food budget and preferences. Materials will be available in print and Web-based. This state-of-the art intervention will then use electronic feedback in the form of nudge messages designed to motivate participants to sustain or improve adherence to the Med-style Food Pattern. Every two weeks, participants in the intervention arm will be prompted via a digital online platform (analog also available) to complete the 14-item Mediterranean Diet Assessment Score (MEDAS) (an adapted version of the MEDAS Score previously used in the Prevencion con Dieta Mediterranea \[PREDIMED study\]) for the purpose of providing timely, individual feedback on diet adherence (not for assessing adherence to the diet pattern). The MEDAS score will be calculated via the online digital platform and ranked according to 3 cutpoints: ≤7, 8-9, or ≥10. Patients will be encouraged to achieve a score of ≥10 which is considered high adherence. The platform will then offer feedback based on the levels of self-reported adherence to the diet including self vs. peer comparisons and support resources. Nudge messages will utilize information from a baseline assessment of participants' dietary attitudes and beliefs about which food groups within a Med-style food pattern they perceive to be most within their control. Ultimately, this approach will enable us to provide participants with dietary information and services that support adherence by accounting for attitudes, norms, and perceived control. The extent of interaction with the online platform will be assessed bi-weekly; degree of adherence to the USDA Med-style food pattern; and engagement in dietician services will be assessed at quarterly intervals.

Participants randomized to the High Fiber Diet Arm will be given commonly used patient education pamphlet, describing fiber and high-fiber foods, the rationale for increasing fiber intake, and ways patients can promote greater intake. Based on prior observational studies of incident diverticulitis, at least 25 grams/day of fiber will be recommended for participants.

Eligibility criteria: Inclusion Criteria:

* Adult ≥18 years;
* Patients presenting (or recently presented) to gastroenterologist or surgeons or accessing study website after recovery from an episode of diverticulitis (within the prior 18 months), either the index episode or recurrent.
* Ability to provide written informed consent in English.

Exclusion Criteria:

* Unable or unwilling to return for specimen collection visits or be contacted for and/or complete research surveys;
* Currently incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening;
* Last episode of acute diverticulitis currently unresolved (i.e., on antibiotics for diverticulitis; drain in place);
* Intolerance/allergy to the main components of the Med-style food pattern;
* Surgery for diverticulitis within past 6 months without an episode of diverticulitis post-surgery;
* Planned elective surgery in next 6 months

Primary outcomes:
measure: Willingness to enroll
timeFrame: through study completion, over a period of 2 years
measure: Adherence to Med-Style Food Pattern
timeFrame: through study completion, over a period of 12 months
measure: Participant retention
timeFrame: through study completion, over a period of 12 months
measure: Engagement with nutrition services
timeFrame: Quarterly through study completion, over a period of 12 months
measure: Interaction with online program
timeFrame: Bi-weekly through study completion, over a period of 12 months
Secondary outcomes:
measure: Change in Plasma, Interleukin (IL)-6, IL-10, IL-1b, fecal calprotectin
timeFrame: Baseline, 6, 12 months through study completion, over a period of 12 months
measure: Diverticulitis events
timeFrame: Quarterly through study completion, over a period of 12 months
measure: National Surgical Quality Improvement Program (NSQIP)-defined complications, a subset of which are serious adverse events to be reported to Independent Safety Monitor
timeFrame: Quarterly through study completion, over a period of 12 months
measure: Change in Diverticulitis Quality of Life Survey (DVQOL)
timeFrame: Baseline, 6, 12 months
measure: Change in Gastrointestinal Quality of Life Index (GIQLI)
timeFrame: Baseline, 6, 12 months
measure: Change in International Physical Activity Questionnaire (IPAQ) short form
timeFrame: Baseline, 6, 12 months
measure: Healthcare utilization
timeFrame: Quarterly through study completion, at 3, 6, 9, 12 months
measure: Change in self-reported weight
timeFrame: Baseline, 6, 12 months
Other outcomes:
Locations:
city: Seattle
country: United States
facility: Harborview Medical Center
state: Washington
Study officials:
affiliation: University of Washington
name: David R Flum, MD, MPH
role: PRINCIPAL_INVESTIGATOR
References: